3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
43
Lymphoma, Mantle-Cell
29
Lymphoma, Follicular
27
Lymphoma
27
Lymphoma, Non-Hodgkin
24
Leukemia, Lymphocytic, Chronic, B-Cell
24
Lymphoma, B-Cell, Marginal Zone
15
Lymphoma, B-Cell
14
Recurrence
12
Burkitt Lymphoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
9
Neoplasms
9
Waldenstrom Macroglobulinemia
8
Leukemia, Hairy Cell
5
Lymphoproliferative Disorders
4
Leukemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
Hodgkin Disease
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm, Residual
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Infections
2
Hematologic Neoplasms
2
Epstein-Barr Virus Infections
2
Interventions
Pemetrexed
4
Spinal Puncture
3
Radiotherapy
3
aflutinib
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Bevacizumab
2
toripalimab
1
sintilimab
1
pertuzumab
1
lorlatinib
1
azeliragon
1
adavosertib
1
Trastuzumab
1
Referral and Consultation
1
Radiation
1
Physical Examination
1
Immunotherapy, Adoptive
1
Immune Checkpoint Inhibitors
1
GDC-0084
1
Drug Therapy
1
Deferoxamine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Meningeal Carcinomatosis
×
Rituximab
×
90 days
×
Clear all
No trials found.